Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications

Abstract

Nanotechnology has played an important role in drug delivery and biomedical imaging over the past two decades. In particular, nanoscale metal-organic frameworks (nMOFs) are emerging as an important class of biomedically relevant nanomaterials due to their high porosity, multifunctionality, and biocompatibility. The high porosity of nMOFs allows for the encapsulation of exceptionally high payloads of therapeutic and/or imaging cargoes while the building blocks-both ligands and the secondary building units (SBUs)-can be utilized to load drugs and/or imaging agents via covalent attachment. The ligands and SBUs of nMOFs can also be functionalized for surface passivation or active targeting at overexpressed biomarkers. The metal ions or metal clusters on nMOFs also render them viable candidates as contrast agents for magnetic resonance imaging, computed tomography, or other imaging modalities. This review article summarizes recent progress on nMOF designs and their exploration in biomedical areas. First, the therapeutic applications of nMOFs, based on four distinct drug loading strategies, are discussed, followed by a summary of nMOF designs for imaging and biosensing. The review is concluded by exploring the fundamental challenges facing nMOF-based therapeutic, imaging, and biosensing agents. This review hopefully can stimulate interdisciplinary research at the intersection of MOFs and biomedicine.

Nanocatalytic Medicine

“…For the fabrication of nanocatalytic medicine, one general approach is to take advantage of wet‐chemical approaches for the in situ growth of nanocatalysts (such as CeO 2 nanoparticles) in solutions, followed by proper surface engineering to impart biocompatibility and multifunctionality. The other method is to synthesize various nanocarriers in well‐controlled manners, such as liposome, MSNs, mesoporous organosilica nanoparticles (MONs), metal‐organic frameworks (MOFs), etc., and then to load molecular catalytic agents (such as enzymes) for the construction of composite nanocatalysts. Moreover, armed with the recent achievements in single‐atom catalysis, in which transition metal atoms are isolated on specific nanodimensional supporters for achieving higher catalytic efficiencies, the list of nanocatalytic medicines has been further enriched to provide more alternative but feasible nanoagents for catalytic therapeutics …”

A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines

“…In the past few decades since its emergence, nanotechnology has offered a variety of innovative solutions that enable specific medical interventions at the molecular scale for prevention, diagnosis, and treatment of diseases as well as repair of tissues by taking advantage of nanomaterials with unique optical, thermal, magnetic, or redox properties . Thanks to the fruitful research driven by innovators across various disciplines, these solutions have exhibited great potential in addressing the hurdles in current pharmaceutics and have given birth to an exciting era of nanomedicine.…”

Self‐Supported Electrocatalysts for Efficient Oxygen Evolution Reaction: Hierarchical CuOx@CoO Nanorods Grown on Cu Foam

“…Metal‐organic frameworks (MOFs) as new porous materials develop in recent years, which are formed by inorganic metal center and organic ligands . Because of the distinctive architectures, MOFs have broad applications in the fields of catalysis, separation, sensing, drug delivery, as well as gas storage . In recent years, MOFs have also been proved to be precursors for the preparation of porous metal oxides and carbon materials with particular activities .…”